Actinium Pharmaceuticals reported $5.34M in Operating Expenses for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Abbvie ABBV:US $ 9518M 611M
Actinium Pharmaceuticals ATNM:US $ 5.34M 653K
Amgen AMGN:US $ 5.7B 1.93B
Capricor Therapeutics CAPR:US $ 4.97M 232.81K
Immunogen IMGN:US $ 44.32M 305K
Pfizer PFE:US $ 13063M 3998M
Seattle Genetics SGEN:US $ 478.08M 23.68M
Spectrum Pharmaceuticals SPPI:US $ 44.07M 10.38M
Sunesis Pharmaceuticals SNSS:US $ 9.06M 69.78M